• All Courts
  • Federal Courts
  • Bankruptcies
  • PTAB
  • ITC
Track Search
Export
Download All
Displaying 39-53 of 249 results

1057 Exhibit: Petitioners Demonstrative Exhibits

Document IPR2020-01053, No. 1057-169 Exhibit - Petitioners Demonstrative Exhibits (P.T.A.B. Aug. 9, 2021)

cite Cite Document

1054 Exhibit: Public Version Stahl Deposition Transcript

Document IPR2020-01053, No. 1054-167 Exhibit - Public Version Stahl Deposition Transcript (P.T.A.B. Jun. 24, 2021)

cite Cite Document

1055 Exhibit: Public Version Reisetter Deposition Transcript

Document IPR2020-01053, No. 1055-168 Exhibit - Public Version Reisetter Deposition Transcript (P.T.A.B. Jun. 24, 2021)

cite Cite Document

1051 Exhibit: Supplemental Declaration Dr Kosten, MD

Document IPR2020-01053, No. 1051-161 Exhibit - Supplemental Declaration Dr Kosten, MD (P.T.A.B. Jun. 10, 2021)

cite Cite Document

1052 Exhibit: Claim Construction Brief in District Court

Document IPR2020-01053, No. 1052-162 Exhibit - Claim Construction Brief in District Court (P.T.A.B. Jun. 10, 2021)

cite Cite Document

1056 Exhibit: Morrison

Document IPR2020-01053, No. 1056-166 Exhibit - Morrison (P.T.A.B. Jun. 10, 2021)

cite Cite Document

1053 Exhibit: Claim Construction Brief at Federal Circuit

Document IPR2020-01053, No. 1053-163 Exhibit - Claim Construction Brief at Federal Circuit (P.T.A.B. Jun. 10, 2021)

cite Cite Document

2064 Exhibit: Correll et al, Effects of Olanzapine Combined With Samidorphan onW...

Document IPR2020-01053, No. 2064-115 Exhibit - Correll et al, Effects of Olanzapine Combined With Samidorphan onWeight Gain in Schizophrenia (P.T.A.B. Mar. 11, 2021)

cite Cite Document

2053 Exhibit: Lombardo et al, Two 6 Week, randomized, Double Blind, Placebo Con...

Document IPR2020-01053, No. 2053-102 Exhibit - Lombardo et al, Two 6 Week, randomized, Double Blind, Placebo Controlled Studies of Ziprasidone in Outpatients with Bipolar IDepression (P.T.A.B. Mar....

cite Cite Document

2057 Exhibit: Fala, Latuda Lurasidone HCL Receives 2 New Indications for Usein B...

Document IPR2020-01053, No. 2057-106 Exhibit - Fala, Latuda Lurasidone HCL Receives 2 New Indications for Usein Bipolar Depression as Monotherapy and as Adjunctive Therapy withLithium or Valproa...

cite Cite Document

2073 Exhibit: Jancin, Newer Atypical Antipsychotics Draw Praise

Document IPR2020-01053, No. 2073-123 Exhibit - Jancin, Newer Atypical Antipsychotics Draw Praise (P.T.A.B. Mar. 11, 2021)

cite Cite Document

2049 Exhibit: Seroquel Label

Document IPR2020-01053, No. 2049-98 Exhibit - Seroquel Label (P.T.A.B. Mar. 11, 2021)

cite Cite Document

2067 Exhibit: DiMasi et al The price of innovation new estimates of drugdevelopmen...

Document IPR2020-01053, No. 2067-117 Exhibit - DiMasi et al The price of innovation new estimates of drugdevelopment costs (P.T.A.B. Mar. 11, 2021)

cite Cite Document

2055 Exhibit: Pacher et al, Cardiovascular Side Effects of New Antidepressants an...

Document IPR2020-01053, No. 2055-104 Exhibit - Pacher et al, Cardiovascular Side Effects of New Antidepressants andAntipsychotics (P.T.A.B. Mar. 11, 2021)

cite Cite Document

2070 Exhibit: Latuda Product Monograph

Document IPR2020-01053, No. 2070-120 Exhibit - Latuda Product Monograph (P.T.A.B. Mar. 11, 2021)

cite Cite Document
<< 1 2 3 4 5 6 7 ... 16 17 18 >>